Immunogenicity of a foot-and-mouth disease (FMD) vaccine against serotypes O, A, SAT-2, and Asia-1 in the Middle East and many parts of Africa, Southeast Asia and Europe

口蹄疫疫苗在中东、非洲、东南亚和欧洲许多地区对O、A、SAT-2和Asia-1血清型的免疫原性

阅读:1

Abstract

Control of foot-and-mouth disease (FMD) is hampered by inadequate biosecurity measures, border transcending serotype strains and unavailability of broad coverage vaccines. In this investigation, six FMD antibody-free calves, aged 1.5-2 years, received a tetravalent, inactivated, aluminum hydroxide gel vaccine (Aphthovac-4) containing 6 PD(50)/dose of certain strains for protection against a wide range of strains in the Middle East, Africa, Southeast Asia, and parts of Europe. The vaccine contained 2 strains of serotype A/Asia (A/Asia (A/Iran-05 and A/Ind/40/2000 G-VII), 2 of serotype O (O/Middle East-South Asia topotype and O/Manisa/TUR/69), and one strain each of serotype SAT-2 (topotype VII) and Asia-1 (Sindh-8). Primary and booster doses were administered 3 weeks apart and sera were collected one week after the booster vaccination, preserved frozen then shipped to The Pirbright Institute, UK, for antibody evaluation by virus neutralization test (VNT) against 22 lineages circulating in the targeted regions. Serum titers against test strains of serotype A were high (range = 355- < 1413 or 2.6- < 3.15 log(10)), and those demonstrating relatively lower values included A/Irn/25/18 (G-VII), A/Irn-05 Far-11, A/Iran05 SIS-13 and SEA-97. Serotype O test strains presented higher titers (≤ 1/1413 or ≤ 3.0 log(10)), but O/Cathay, O/Panasia-2 ant-10 and one O/Ind-2001e lineage exhibited somewhat lower values (range (355-1024 or 2.6-3.01 log(10)). Antibodies against SAT-2 test strains (XIV Topotype) ranged between 128 and 178 (1.9-2.2 log(10)) in 5 animals (5/6, 83%), despite the reported high r1 values. Likewise, Asia-1 strain elicited a similar titer range against IRN/1/2020 in the same 5 animals. The 6th animal generally showed one dilution less. The results portray a dynamic antigenic change between the vaccinal and test strains, underscoring the value of strain matching, use of high payload and incorporation of double antigen lineages within each serotype to broaden coverage in enzootic and epizootic situations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。